From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
GTN Analytics allows reporting, visualizations, and exports to your entire pharmaceutical market access, finance, and executive team–keeping everyone informed with near real-time access to your data that can improve visibility, efficiency, and company-wide collaboration.
With most managerial teams requesting “big picture” insight into their pharma market access strategy, GTN Analytics allows teams to streamline their reporting and analysis process by uniquely integrating financial data with channel and patient data, including national demand, third-party logistics, specialty pharmacy, specialty distribution, and rebate data.
IntegriChain’s GTN Analytics comes with numerous pre-defined reports but one of the more popular capabilities is the ability to run ad-hoc reports on various domains of close and forecast. For example, users can create the following reports:
One of the most common uses of GTN Analytics is to view a comparison between the current close month accrual and compare it to the trend for a selected forecast. Manufacturers can view the delta between the current close month accrual and compare it to the trend for a selected forecast. Users will be able to view the reports based on all of the value types such as accruals $, accrual %, units, discount %, and utilization % for the current close month and compare the trend to a forecast.
GTN Analytics provides comprehensive waterfall reporting to provide a simple, visual breakdown of the commercialization costs which make up the difference between sale price and net-revenue.
GTN waterfall report also serves as a starting point for net revenue optimization analyses and exploration into ways to improve margin. For example, the report may help pharma commercial leadership and finance teams with the following:
IntegriChain’s GTN Analytics solution is part of our broader GTN solution that delivers on four distinct types of capabilities:
Learn how to Maximize Net-Price Visibility and Predictability
Whether manufacturers are entering new therapeutic categories, exploring new indications for a current product, or looking to acquire a new product through acquisition, portfolio growth presents both opportunities and challenges.
Read the Blog
In the current pharmaceutical landscape, more than 80% of manufacturers still rely on manual processes to accrue, forecast, and report their gross-to-net (GTN) deductions.However, in the era of big data and technological enhancements, manual processes cannot be relied on forever.
